- Home
- IMCR vs TNK Comparison
IMCR vs TNK Comparison
Compare IMCR & TNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- TNK
- Stock Information
- Founded
- IMCR 2008
- TNK 2007
- Country
- IMCR United Kingdom
- TNK Bermuda
- Employees
- IMCR N/A
- TNK N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- TNK Marine Transportation
- Sector
- IMCR Health Care
- TNK Consumer Discretionary
- Exchange
- IMCR Nasdaq
- TNK Nasdaq
- Market Cap
- IMCR 1.5B
- TNK 1.6B
- IPO Year
- IMCR 2021
- TNK 2007
- Fundamental
- Price
- IMCR $31.34
- TNK $45.38
- Analyst Decision
- IMCR Buy
- TNK Buy
- Analyst Count
- IMCR 10
- TNK 3
- Target Price
- IMCR $58.13
- TNK $50.67
- AVG Volume (30 Days)
- IMCR 560.7K
- TNK 458.3K
- Earning Date
- IMCR 08-07-2025
- TNK 07-31-2025
- Dividend Yield
- IMCR N/A
- TNK 4.39%
- EPS Growth
- IMCR N/A
- TNK N/A
- EPS
- IMCR N/A
- TNK 9.52
- Revenue
- IMCR $333,581,000.00
- TNK $1,092,689,000.00
- Revenue This Year
- IMCR $26.82
- TNK N/A
- Revenue Next Year
- IMCR $8.15
- TNK N/A
- P/E Ratio
- IMCR N/A
- TNK $4.90
- Revenue Growth
- IMCR 25.75
- TNK N/A
- 52 Week Low
- IMCR $23.15
- TNK $33.35
- 52 Week High
- IMCR $41.54
- TNK $72.30
- Technical
- Relative Strength Index (RSI)
- IMCR 40.28
- TNK 51.95
- Support Level
- IMCR $35.10
- TNK $45.09
- Resistance Level
- IMCR $37.56
- TNK $47.99
- Average True Range (ATR)
- IMCR 1.74
- TNK 1.61
- MACD
- IMCR -0.79
- TNK 0.04
- Stochastic Oscillator
- IMCR 0.75
- TNK 55.79
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About TNK Teekay Tankers Ltd.
Teekay Tankers Ltd is a provider of marine services to the global oil and natural gas industries and an operator of medium-sized oil tankers. The company operates in two segments: Tankers, which consists of the operation of all of the company's tankers (including the operations from those tankers employed on full service lightering contracts), and the company's U.S. based ship-to-ship support service operations (including its lightering support services provided as part of full service lightering operations); and Marine Services, which consists of operational and maintenance marine services provided to the Australian government, Australian energy companies and other third parties. The company generates the majority of its revenue from the Tankers segment.